NasdaqCM - Delayed Quote • USD
Biofrontera Inc. (BFRI)
At close: April 26 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -1.17 | -1.12 | -3.24 | -0.54 |
| Low Estimate | -1.63 | -1.33 | -4.01 | -0.9 |
| High Estimate | -0.71 | -0.92 | -2.48 | -0.19 |
| Year Ago EPS | -5.6 | -7.23 | -13.02 | -3.24 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 10.86M | 8.61M | 40.7M | 49.94M |
| Low Estimate | 10.2M | 7.4M | 40.5M | 48.2M |
| High Estimate | 11.51M | 9.81M | 40.9M | 51.67M |
| Year Ago Sales | 8.73M | 5.85M | 34.07M | 40.7M |
| Sales Growth (year/est) | 24.40% | 47.20% | 19.50% | 22.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -3.9 | -4.61 | -3.78 | -1.19 |
| EPS Actual | -5.6 | -7.23 | -4.64 | 1.65 |
| Difference | -1.7 | -2.62 | -0.86 | 2.84 |
| Surprise % | -43.60% | -56.80% | -22.80% | 238.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.17 | -1.12 | -3.24 | -0.54 |
| 7 Days Ago | -1.17 | -1.12 | -3.24 | -0.54 |
| 30 Days Ago | -1.17 | -1.12 | -3.24 | -0.54 |
| 60 Days Ago | -0.77 | -1.16 | -3.07 | -0.37 |
| 90 Days Ago | -0.77 | -1.16 | -3.07 | -0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BFRI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 79.10% | -- | -- | 5.40% |
| Next Qtr. | 84.50% | -- | -- | 10.90% |
| Current Year | 75.10% | -- | -- | 4.50% |
| Next Year | 83.30% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Benchmark: Buy to Buy | 8/31/2023 |
Related Tickers
PTPI Petros Pharmaceuticals, Inc.
0.6399
0.00%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3850
-0.90%
SNOA Sonoma Pharmaceuticals, Inc.
0.1590
-1.18%
SXTC China SXT Pharmaceuticals, Inc.
1.0500
+1.94%
MEDXF Medexus Pharmaceuticals Inc.
1.3850
+2.59%
RDHL RedHill Biopharma Ltd.
0.4280
+2.22%
SBFM Sunshine Biopharma, Inc.
0.9500
+17.66%
LSDI Lucy Scientific Discovery Inc.
0.7597
-12.58%
OPTN OptiNose, Inc.
0.8604
-4.93%
AGRX Agile Therapeutics, Inc.
0.4000
0.00%